Search Results

You are looking at 11 - 20 of 1,186 items for :

  • "screening" x
  • Refine by Access: All x
Clear All
Full access

Low Provider Knowledge Is Associated With Less Evidence-Based Lung Cancer Screening

Jennifer A. Lewis, Heidi Chen, Kathryn E. Weaver, Lucy B. Spalluto, Kim L. Sandler, Leora Horn, Robert S. Dittus, Pierre P. Massion, Christianne L. Roumie, and Hilary A. Tindle

5-year survival of only 18%. 1 Low-dose CT (LDCT) can detect early-stage lung cancer, increasing the likelihood of cure. The National Lung Screening Trial (NLST), a large, multicenter, US randomized controlled trial, was terminated early when it

Full access

Patterns and Trends of Cancer Screening in Canada: Results From a Contemporary National Survey

Omar Abdel-Rahman

Background Cancer screening programs represent a pivotal component of all cancer care programs among different Canadian jurisdictions. 1 Previously published evidence has shown that targeted screening for some solid tumors is associated with

Full access

Breast MRI as a Screening Tool: The Appropriate Role

Huong T. Le-Petross

BRCA2 mutation carriers . Cancer Res 2006 ; 66 : 1866 – 1872 . 8. Lehman CD Blume JD Weatherall P . Screening women at high risk for breast cancer with mammography and magnetic resonance imaging . Cancer 2005 ; 103 : 1898 – 1905

Full access

Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center

Harrys A. Torres, Khalis Mustafayev, Ruston P. Juneau, Jessica P. Hwang, Lan Sun Wang, Georgios Angelidakis, Ernest Hawk, Bruno P. Granwehr, Eduardo Yepez Guevara, and Anita K. Ying

ranges from 1.5% to 2.4%, but these prevalences may be inaccurate due to the lack of routine HCV screening in many cancer centers. 11 – 13 Chronic HCV infection causes virologic, hepatic, and oncologic concerns in patients with cancer. 10 Our group has

Full access

A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer

Sean Dineen, Patrick M. Lynch, Miguel A. Rodriguez-Bigas, Sarah Bannon, Melissa Taggart, Colleen Reeves, Cathy Modaro, Michael Overman, George J. Chang, John M. Skibber, and Y. Nancy You

analytic models. 8 , 13 , 14 The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for CRC Screening have evolved to place increasing emphasis on molecular testing for detection of hereditary cancer syndromes, specifically testing for MMR

Full access

SupportScreen: A Model for Improving Patient Outcomes

Matthew Loscalzo, Karen Clark, Jeff Dillehunt, Redmond Rinehart, Rex Strowbridge, and Daniel Smith

-offsetting advantages of addressing biopsychosocial issues, despite the effort and cost of establishing an automated screening/triage system. 3 – 5 These include cost benefits to hospitals providing psychosocial care, 3 and the potential for psychological distress

Full access

Potential Cost-Effectiveness of Risk-Based Pancreatic Cancer Screening in Patients With New-Onset Diabetes

Naomi R.M. Schwartz, Lynn M. Matrisian, Eva E. Shrader, Ziding Feng, Suresh Chari, and Joshua A. Roth

the development and implementation of effective screening for idiopathic PAC is the low incidence of disease. Annualized PAC incidence is approximately 13.1 patients per 100,000 individuals across the entire US population, but 90% of patients are aged

Full access

Prostate Cancer Screening and Determining the Appropriate Prostate-Specific Antigen Cutoff Values

William J. Catalona and Stacy Loeb

T he prostate-specific antigen (PSA) blood test is the foundation for modern prostate cancer (CaP) screening. Initially it was used in forensic medicine. The subsequent discovery that it could be measured in serum, and that serum levels increase

Full access

Point: Justification for Lynch Syndrome Screening Among All Patients With Newly Diagnosed Colorectal Cancer

Heather Hampel

their relatives to undergo genetic counseling and testing to learn if they too are at increased risk for cancer and could benefit from intensive cancer surveillance. The costs of screening can be offset by the benefits of cancer prevention in the patient

Full access

Practical Advances in Stool Screening for Colorectal Cancer

Jonathan Potack and Steven H. Itzkowitz

Colorectal cancer (CRC) is a very common and often fatal cancer in the United States and worldwide. Screening has been shown to be highly effective in preventing the incidence and subsequent mortality from CRC, and has been endorsed by all major